Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
A blockbuster oncology drug showed great promise in new indications, but the pharmaceutical company marketing the drug did not have the capacity to supply the 125,000 vials per month that would be needed to support its new clinical trials.
Download this case study to learn how:
- Lean manufacturing techniques were applied to streamline processes
- Label modifications enabled increased quality and throughput
- Operational improvements enabled achieving a targeted 9 day cycle time